138 related articles for article (PubMed ID: 35117923)
21. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
[TBL] [Abstract][Full Text] [Related]
22. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
23. Rab27b is a potential predictor for metastasis and prognosis in colorectal cancer.
Bao J; Ni Y; Qin H; Xu L; Ge Z; Zhan F; Zhu H; Zhao J; Zhou X; Tang X; Tang L
Gastroenterol Res Pract; 2014; 2014():913106. PubMed ID: 25580113
[TBL] [Abstract][Full Text] [Related]
24. Gab2 is a novel prognostic factor for colorectal cancer patients.
Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
[TBL] [Abstract][Full Text] [Related]
26. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
[TBL] [Abstract][Full Text] [Related]
27. Correlation between miR-21 and miR-145 and the incidence and prognosis of colorectal cancer.
Liu Q; Yang W; Luo Y; Hu S; Zhu L
J BUON; 2018; 23(1):29-35. PubMed ID: 29552756
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of Ankyrin repeat domain 12 expression in colorectal cancer.
Bai R; Li D; Shi Z; Fang X; Ge W; Zheng S
J Exp Clin Cancer Res; 2013 May; 32(1):35. PubMed ID: 23718802
[TBL] [Abstract][Full Text] [Related]
29. p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.
Yuan XS; Zhang Y; Guan XY; Dong B; Zhao M; Mao LL; Lu YY; Tian XY; Hao CY
J Cancer Res Clin Oncol; 2013 Jul; 139(7):1211-20. PubMed ID: 23576022
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-17 is a favorable prognostic marker for colorectal cancer.
Lin Y; Xu J; Su H; Zhong W; Yuan Y; Yu Z; Fang Y; Zhou H; Li C; Huang K
Clin Transl Oncol; 2015 Jan; 17(1):50-6. PubMed ID: 25015721
[TBL] [Abstract][Full Text] [Related]
31. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
Ma J; Zhang S; Hu Y; Li X; Yuan F; Sun D; Wang L; Zhang F; Chen G; Cui P
Medicine (Baltimore); 2017 Oct; 96(42):e7011. PubMed ID: 29049167
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
[TBL] [Abstract][Full Text] [Related]
33. CXCL10 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Xu Y; Cai S
Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051
[TBL] [Abstract][Full Text] [Related]
34. Expression and Clinical Significance of POLR1D in Colorectal Cancer.
Tian Y; Sun F; Zhong Y; Huang W; Wang G; Liu C; Xiao Y; Wu J; Mu L
Oncology; 2020; 98(3):138-145. PubMed ID: 31722331
[TBL] [Abstract][Full Text] [Related]
35. [Expression of circadian gene NPAS2 in colorectal cancer and its prognostic significance].
Yang SF; Xu M; Yang HY; Li PQ; Chi XF
Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):714-8. PubMed ID: 27222192
[TBL] [Abstract][Full Text] [Related]
36. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of the long noncoding RNA CRNDE-h indicates a poor prognosis in colorectal cancer, and is positively correlated with IRX5 mRNA expression.
Liu T; Zhang X; Yang YM; Du LT; Wang CX
Onco Targets Ther; 2016; 9():1437-48. PubMed ID: 27042112
[TBL] [Abstract][Full Text] [Related]
39. Association of the upregulation of LncRNA00673 with poor prognosis for colorectal cancer.
Feng LM; Zhao DW; Li SJ; Huang J
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):687-694. PubMed ID: 29461596
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of microRNA-16 expression in human colorectal cancer.
Qian J; Jiang B; Li M; Chen J; Fang M
World J Surg; 2013 Dec; 37(12):2944-9. PubMed ID: 24045965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
